CDMO News

Excellos to Manufacture Galapagos’ CAR-T Therapy for U.S. Clinical Trial

  • Excellos Inc. selected to manufacture Galapagos’ CAR-T cell therapy for the ATALANTA-1 clinical trial.
  • Manufacturing will take place at Excellos’ facility in San Diego, with a seven-day vein-to-vein time.

Excellos Inc., a contract development and manufacturing organisation (CDMO) and member of Blood Centers of America (BCA), has been selected to manufacture Galapagos’ CAR-T cell therapy candidate, GLPG5101. The production will support the recently FDA-cleared ATALANTA-1 clinical study targeting relapsed or refractory non-Hodgkin lymphoma patients in the U.S.

The end-to-end manufacturing process will be carried out at Excellos’ new facility in San Diego, California. Galapagos’ decentralized platform aims to improve CAR-T cell therapy production by offering faster delivery and greater scalability. With a median vein-to-vein time of seven days, the process also allows physicians more control, potentially improving patient outcomes.

“We are excited to manufacture Galapagos’ CAR-T cell therapy candidate using their decentralized manufacturing platform,” said Thomas VanCott, CEO of Excellos. He noted that the collaboration would enable efficient production and delivery of fresh CAR-T cells within a short timeframe, leveraging the company’s facility and expertise.

The agreement marks the first site initiation under the strategic collaboration between Galapagos’ U.S. entity, GLPG US, Inc., and BCA. This initiative will see BCA’s national network of blood centers providing decentralized manufacturing services near cancer treatment centers across the U.S., offering faster access to innovative therapies.

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

ELEARNING

Learn the essentials of successful biopharma outsourcing

New eLearning course distils 100+ expert interviews into 10 engaging modules.

tick Overview of outsourcing trends 
tick Expert insights and case studies 
tick Helpful resources and quizzes

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.